Andrew Mok
Stock Analyst at Barclays
(3.54)
# 846
Out of 5,146 analysts
268
Total ratings
52.94%
Success rate
3.97%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADUS Addus HomeCare | Maintains: Underweight | $117 → $112 | $103.69 | +8.01% | 5 | Feb 24, 2026 | |
| HCA HCA Healthcare | Maintains: Buy | $598 → $635 | $533.56 | +19.01% | 18 | Feb 23, 2026 | |
| THC Tenet Healthcare | Maintains: Overweight | $240 → $257 | $236.66 | +8.59% | 17 | Feb 13, 2026 | |
| MOH Molina Healthcare | Maintains: Underweight | $164 → $133 | $148.54 | -10.46% | 12 | Feb 10, 2026 | |
| EHC Encompass Health | Maintains: Overweight | $150 → $153 | $104.50 | +46.41% | 19 | Feb 6, 2026 | |
| CI The Cigna Group | Maintains: Overweight | $305 → $303 | $284.64 | +6.45% | 11 | Feb 6, 2026 | |
| DVA DaVita | Maintains: Buy | $186 → $190 | $146.20 | +29.96% | 15 | Feb 4, 2026 | |
| BKD Brookdale Senior Living | Maintains: Overweight | $15 → $18 | $15.17 | +18.69% | 3 | Feb 3, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $391 → $327 | $281.65 | +16.10% | 15 | Jan 30, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $404 → $393 | $330.90 | +18.77% | 16 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $263 → $262 | $229.96 | +13.93% | 26 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $9 → $11 | $7.10 | +54.93% | 3 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $234 → $245 | $177.61 | +37.94% | 15 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $13 → $18 | $12.69 | +41.90% | 4 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $44 → $54 | $42.94 | +25.76% | 13 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 → $93 | $76.16 | +22.11% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $14 | $21.56 | -35.06% | 19 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $36 → $26 | $19.91 | +30.59% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $24 → $18 | $15.52 | +16.02% | 5 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $79 → $86 | $68.05 | +26.39% | 9 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $22 → $23 | $22.14 | +3.91% | 10 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $1.5 → $1 | $0.44 | +128.78% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $18 | $20.00 | -10.00% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $4 → $3.5 | $3.55 | -1.41% | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $13.58 | -11.63% | 1 | Dec 8, 2022 |
Addus HomeCare
Feb 24, 2026
Maintains: Underweight
Price Target: $117 → $112
Current: $103.69
Upside: +8.01%
HCA Healthcare
Feb 23, 2026
Maintains: Buy
Price Target: $598 → $635
Current: $533.56
Upside: +19.01%
Tenet Healthcare
Feb 13, 2026
Maintains: Overweight
Price Target: $240 → $257
Current: $236.66
Upside: +8.59%
Molina Healthcare
Feb 10, 2026
Maintains: Underweight
Price Target: $164 → $133
Current: $148.54
Upside: -10.46%
Encompass Health
Feb 6, 2026
Maintains: Overweight
Price Target: $150 → $153
Current: $104.50
Upside: +46.41%
The Cigna Group
Feb 6, 2026
Maintains: Overweight
Price Target: $305 → $303
Current: $284.64
Upside: +6.45%
DaVita
Feb 4, 2026
Maintains: Buy
Price Target: $186 → $190
Current: $146.20
Upside: +29.96%
Brookdale Senior Living
Feb 3, 2026
Maintains: Overweight
Price Target: $15 → $18
Current: $15.17
Upside: +18.69%
UnitedHealth Group
Jan 30, 2026
Maintains: Overweight
Price Target: $391 → $327
Current: $281.65
Upside: +16.10%
Elevance Health
Jan 30, 2026
Maintains: Overweight
Price Target: $404 → $393
Current: $330.90
Upside: +18.77%
Jan 22, 2026
Maintains: Overweight
Price Target: $263 → $262
Current: $229.96
Upside: +13.93%
Jan 16, 2026
Maintains: Overweight
Price Target: $9 → $11
Current: $7.10
Upside: +54.93%
Jan 5, 2026
Maintains: Equal-Weight
Price Target: $234 → $245
Current: $177.61
Upside: +37.94%
Jan 5, 2026
Upgrades: Equal-Weight
Price Target: $13 → $18
Current: $12.69
Upside: +41.90%
Jan 5, 2026
Upgrades: Overweight
Price Target: $44 → $54
Current: $42.94
Upside: +25.76%
Dec 10, 2025
Maintains: Overweight
Price Target: $87 → $93
Current: $76.16
Upside: +22.11%
Dec 4, 2025
Maintains: Equal-Weight
Price Target: $17 → $14
Current: $21.56
Upside: -35.06%
Nov 24, 2025
Maintains: Equal-Weight
Price Target: $36 → $26
Current: $19.91
Upside: +30.59%
Nov 21, 2025
Maintains: Equal-Weight
Price Target: $24 → $18
Current: $15.52
Upside: +16.02%
Nov 13, 2025
Maintains: Overweight
Price Target: $79 → $86
Current: $68.05
Upside: +26.39%
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $22 → $23
Current: $22.14
Upside: +3.91%
Nov 6, 2025
Maintains: Underweight
Price Target: $1.5 → $1
Current: $0.44
Upside: +128.78%
Nov 3, 2025
Maintains: Equal-Weight
Price Target: $13 → $18
Current: $20.00
Upside: -10.00%
Jul 24, 2025
Maintains: Equal-Weight
Price Target: $4 → $3.5
Current: $3.55
Upside: -1.41%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $13.58
Upside: -11.63%